Stock SNDX SYNDAX PHARMACEUTICALS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

MarketScreener Editorial Features Syndax Pharmaceuticals, Inc.

Equities

SNDX

US87164F1057

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-06-13 pm EDT 		5-day change 1st Jan Change
20.7 USD +2.12% Intraday chart for Syndax Pharmaceuticals, Inc. +6.70% -4.21%
Jun. 12 Transcript : Syndax Pharmaceuticals, Inc. Presents at Goldman Sachs 45th Annual Global Healthcare Conference, Jun-12-2024 08:40 AM
Jun. 06 Syndax Pharmaceuticals to Progress into Phase 1b Segment of Revumenib Trial MT

MarketScreener Editorial Features

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. SNDX Stock
  4. News Syndax Pharmaceuticals, Inc.
  5. MarketScreener Editorial Features